Professor Alistair Nichol
Contact information
Research groups
Alistair Nichol
MB, BCh, BAO, BA (Health Scien), PhD, FRCARCSI, FJFICMI, FCICM
Professor of Critical Care Medicine
- Honorary Visiting Research Fellow in Tropical Medicine
- Prof (Chair) of Critical Care Medicine, University College Dublin, Ireland.
- Prof, School of Public Health and Preventive Medicine, Monash University, Australia
- Director, Irish Critical Care-Clinical Trials Network (ICC-CTN)
- Deputy Director, Australia and New Zealand Intensive Care-Research Centre (ANZIC-RC)
- Consultant Intensivist / Anaesthetist
Prof Alistair Nichol is the Chair of Critical Care Medicine in University College Dublin (UCD), the Director of the Irish Critical Care-Clinical Trials Network (ICC-CTN), Immediate Past Chair of the Irish Critical Care-Clinical Trials Group (ICC-CTG) and Deputy Director of the Australia and New Zealand Intensive Care-Research Centre (ANZIC-RC). Alistair is a Fellow (Honorary visiting) in Tropical Medicine at Oxford University, where he works with the International Severe Acute Respiratory Infection Consortium (SPRINT-SARI Project). Prof Nichol is a Consultant Intensivist / Anaesthetist at St. Vincent’s University Hospital in Dublin and in the Alfred Hospital in Melbourne.
Prof Alistair Nichol leads a program of critical care research nationally and globally having delivered some of the most pivotal clinical trials worldwide guiding clinical practice. His research focuses are pandemic preparedness and infectious disease (SPRINT-SARI, REMAP-CAP), brain injury (including TBI and secondary brain injury post cardiac arrest) and general critical care (transfusion, renal replacement therapy, gastric prophylaxis). He also has a keen interest in biomarker and trials methodology research including SWATs. He leads a program of public and patient involvement and engagement activities.
Recent publications
-
Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses.
Bruce P. et al, (2022), Trials, 23
-
Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial.
Robba C. et al, (2022), Intensive care medicine
-
Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses.
Bruce P. et al, (2022), Trials, 23
-
People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia.
Begum H. et al, (2022), The Medical journal of Australia
-
Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators.
Moseby-Knappe M. et al, (2022), Resuscitation plus, 10